StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report released on Monday. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of NYSE:CO opened at $1.00 on Monday. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50. The firm’s 50-day simple moving average is $1.21 and its 200-day simple moving average is $1.35. The company has a market cap of $121.55 million, a price-to-earnings ratio of 1.56 and a beta of 0.16.
Global Cord Blood Company Profile
See Also
- Five stocks we like better than Global Cord Blood
- Dividend Capture Strategy: What You Need to Know
- AbbVie Stock: A Perfect Dip for Investors to Buy
- EV Stocks and How to Profit from Them
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Market Cap Calculator: How to Calculate Market Cap
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.